U.S., Sept. 17 -- ClinicalTrials.gov registry received information related to the study (NCT07175285) titled 'A Study in Participants With Active Systemic Lupus Erythematosus With Inadequate Response to Glucocorticoids and >=2 Immunosuppressants' on Sept. 09.

Brief Summary: The purpose of this study is to characterize the efficacy and safety of current standard of care treatment options in participants with active systemic lupus erythematosus (SLE; including lupus nephritis) with inadequate response to glucocorticoids and at least two immunosuppressants

Study Start Date: Nov. 04

Study Type: OBSERVATIONAL

Condition: Systemic Lupus Erythematosus (SLE)

Intervention: DRUG: Current standard of care treatment options

According to the prod...